Search research articles
Contact Us
Filters
Showing results (261-270 of 1,859) with videos related to
Page
of 186
Sort By:
Cardiology in Review
|
September 29, 2012
A new approach to inotropic therapy in the treatment of heart failure: cardiac myosin activators in treatment of HF
Vinisha Garg, William H Frishman
Cardiology in Review
|
April 22, 2021
Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease
Gregory Hemenway, William H Frishman
Cardiology in Review
|
June 20, 2025
The Cardiovascular Benefits of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
Mohammed Kallash, William H Frishman
Cardiology in Review
|
October 22, 2024
Alternative Perspectives on Obesity and Hypertension
Atara Schulhof, William H Frishman
Cardiology in Review
|
May 13, 2025
Connections Between Hypertension, Atherosclerosis, Acute Myocardial Infarction, and Risk of Dementia
Avi Stern, William H Frishman
Cardiology in Review
|
January 3, 2024
Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Review of Clinical Manifestations, Cardiac Complications and Medical Management
Maya Pandit, William H Frishman
Cardiology in Review
|
July 1, 2026
Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice
Christopher Annabi, William H Frishman
Viruses
|
July 27, 2022
Influenza A Virus Infection Reactivates Human Endogenous Retroviruses Associated with Modulation of Antiviral Immunity
Hengyuan Liu, Valter Bergant, Goar Frishman, et al.
Journal of Clinical Pharmacology
|
February 1, 1990
Bile acid sequestrants
M Ast, W H Frishman
Cardiology in Review
|
December 7, 2011
Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications
Natalia Beridze, William H Frishman
Page
of 186
Search research articles
Search
Showing results (261-270 of 1,859) with videos related to
Sort By:
Page
of 186
Cardiology in Review
|
September 29, 2012
A new approach to inotropic therapy in the treatment of heart failure: cardiac myosin activators in treatment of HF
Vinisha Garg, William H Frishman
Cardiology in Review
|
April 22, 2021
Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease
Gregory Hemenway, William H Frishman
Cardiology in Review
|
June 20, 2025
The Cardiovascular Benefits of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
Mohammed Kallash, William H Frishman
Cardiology in Review
|
October 22, 2024
Alternative Perspectives on Obesity and Hypertension
Atara Schulhof, William H Frishman
Cardiology in Review
|
May 13, 2025
Connections Between Hypertension, Atherosclerosis, Acute Myocardial Infarction, and Risk of Dementia
Avi Stern, William H Frishman
Cardiology in Review
|
January 3, 2024
Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Review of Clinical Manifestations, Cardiac Complications and Medical Management
Maya Pandit, William H Frishman
Cardiology in Review
|
July 1, 2026
Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice
Christopher Annabi, William H Frishman
Viruses
|
July 27, 2022
Influenza A Virus Infection Reactivates Human Endogenous Retroviruses Associated with Modulation of Antiviral Immunity
Hengyuan Liu, Valter Bergant, Goar Frishman, et al.
Journal of Clinical Pharmacology
|
February 1, 1990
Bile acid sequestrants
M Ast, W H Frishman
Cardiology in Review
|
December 7, 2011
Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications
Natalia Beridze, William H Frishman
Page
of 186